INgezim COVID 19 CROM (1x25)
Dual recognition immunochromatographic assay capable of detecting specific COVID-19 (SARS-CoV-2) antibodies (IgG, IgA, and IgM) in serum and blood samples. The test is able to detect antibodies specific to SARS-CoV-2 in 94.5%* of cases from day 19. There is no cross-reactivity with antibodies specific to other coronaviruses or agents related to human respiratory illnesses.
*Validation on 153 samples, April 2020
WATCH THIS VIDEO to learn more about the process of using INgezim® COVID 19 CROM!
Not available in the U.S.
The INgezim COVID assays qualitatively determine total antibodies specific to the SARS-CoV-2 virus nucleoprotein (N protein) in human serum or blood samples. The N protein is one of the most abundant early-onset proteins of the virus, as well as being highly immunogenic and therefore a good candidate antigen for the diagnosis of COVID-19.
These rapid, point-of-care tests can be performed outside of the laboratory and are intended for use by healthcare professionals only, NOT for self-diagnosis.
• Quick test - only 10 minutes
• Test kits include all materials required to perform the test (test strip, lancet, pipette and diluent)
• Finger-prick blood extraction
• CE-IVD marked
Let's peek inside the INgezim® COVID 19 CROM video
to learn more about the easy-to-use procedure of our rapid tests.
|Test principle||Immunochromatography assay|
|Analysable samples||Blood and serum samples|
|Assay time||10 min|
|No. of tests||25|